IEHP Pilot Program Published in Journal of Managed Care and Specialty Pharmacy IEHP Latest News and Publications September 21, 2021
In partnership with Surveyor Health, Inland Empire Health Plan’s Pharmacy Comprehensive Medication Management (CMM) Pilot Program, utilizing artificial intelligence (AI) to manage medication use among Members was recently published in the Journal of Managed Care & Specialty Pharmacy.
Artificial Intelligence Can Improve Outcomes and Reduce the Cost of Care Among Higher Risk Patients Erick Von Schweber and Joan Kapusnik-Uner, PharmD, FCSHP, FASHP August 20, 2021 Population Health Learning Network: First Report Managed Care
"FDB's collaboration with Surveyor Health combines the power of our well-curated and vetted drug data and Surveyor’s AI-based technology to help keep patients safer and healthier" said Bob Katter, president of FDB.
Artificial Intelligence Drives a New Medication Management Philosophy HISTalk - By Erick Von Schweber - July 12, 2021
There are times when advances in technology enable a radical re-envisioning of both what we do and how we do it. Medication management is at that stage, thanks to ongoing developments in artificial intelligence....
Economic and Utilization Outcomes of Medication Management at a Large Medicaid Plan with Disease Management Pharmacists using a Novel Artificial Intelligence Platform from 2018 to 2019 Peer reviewed and published by The Journal of Managed Care & Specialty Pharmacy (JMCP)
May 2021 Press Release - JMCP Study - Highlights
Peer reviewed study shows 19.3% reduction in cost of care and validates the ability of remote Population Medication Management to lower costs, reduce hospitalization and ER visits
The key findings published in the Journal of Managed Care & Specialty Pharmacy include:
Regimen Risk Reduction Stats
15.2% reduction in serious drug-drug interactions
13.1% reduction in duplications of therapy
3.9% reduction in additive adverse events
Healthcare Savings Stats
The economic study found a 19.3% reduction in the total cost of care (TCoC) that yielded a savings of $554 Per Member Per Month. This translates to approximately $1.2M a month and over $14M annually for the 2,150 members in the study.
Medication costs alone showed a 17.4% reduction, which yielded a savings of $192 Per Member Per Month.
The utilization study found a 15% reduction in ER visits, a 9% reduction in Hospital Admits, and a 10% reduction in Bed Days.
Return on Investment is 12.4:1 based on TCoC savings and program costs.
Extended to members with similar risks, these interventions will save the Plan at least $109M annually and could save California’s Medi-Cal (Medicaid) nearly $1.2B. This demonstrates how valuable it would be for Medicaid to support this quality of intervention for its members.
The SurveyorAI platform:
Evaluates a multi-drug regimen as a complex system of varying components, assessing the risks posed by numerous medications often being taken at the same time.
Simulates prospective changes to a drug regimen to aid the clinician in deciding the optimal configuration in the face of so many tradeoffs.
Expands the clinician’s knowledge, giving them the ability to, at-a-glance, understand and gain insight into the complexities of the large drug regimens all too common in high risk patients. This improves teamwide clinical consistency.
Reduces overall medication regimen risks, leading to a reduction in healthcare costs. Reducing medication risks improves health and minimizes utilization of services which reduces costs.